Total Payments
$7,129
2023 Payments
$101.12
Companies
9
Transactions
13
Medicare Patients
1,664
Medicare Billing
$309,604
Payment Breakdown by Category
Other$3,598 (50.5%)
Consulting$3,000 (42.1%)
Food & Beverage$367.78 (5.2%)
Education$126.33 (1.8%)
Travel$36.00 (0.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $3,000 | 2 | 42.1% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $2,098 | 2 | 29.4% |
| Honoraria | $1,500 | 1 | 21.0% |
| Food and Beverage | $367.78 | 4 | 5.2% |
| Education | $126.33 | 3 | 1.8% |
| Travel and Lodging | $36.00 | 1 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | $2,899 | 3 | $0 (2018) |
| E.R. Squibb & Sons, L.L.C. | $2,250 | 2 | $0 (2017) |
| Secura Bio, Inc. | $1,598 | 2 | $0 (2020) |
| Merck Sharp & Dohme Corporation | $120.61 | 1 | $0 (2018) |
| Seagen Inc. | $101.12 | 1 | $0 (2023) |
| Amgen Inc. | $99.95 | 1 | $0 (2021) |
| Janssen Scientific Affairs, LLC | $32.71 | 1 | $0 (2018) |
| Acrotech Biopharma LLC | $13.93 | 1 | $0 (2021) |
| Karyopharm Therapeutics Inc. | $12.45 | 1 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $101.12 | 1 | Seagen Inc. ($101.12) |
| 2021 | $113.88 | 2 | Amgen Inc. ($99.95) |
| 2020 | $1,611 | 3 | Secura Bio, Inc. ($1,598) |
| 2018 | $3,053 | 5 | Takeda Pharmaceuticals U.S.A., Inc. ($2,899) |
| 2017 | $2,250 | 2 | E.R. Squibb & Sons, L.L.C. ($2,250) |
All Payment Transactions
13 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/22/2023 | Seagen Inc. | ADCETRIS (Biological) | Food and Beverage | In-kind items and services | $101.12 | General |
| Category: Oncology | ||||||
| 10/28/2021 | Acrotech Biopharma LLC | BELEODAQ (Drug) | Education | In-kind items and services | $13.93 | General |
| Category: ONCOLOGY | ||||||
| 03/04/2021 | Amgen Inc. | — | Education | In-kind items and services | $99.95 | General |
| 11/20/2020 | Karyopharm Therapeutics Inc. | XPOVIO (Drug) | Education | In-kind items and services | $12.45 | General |
| Category: Oncology | ||||||
| 02/25/2020 | Secura Bio, Inc. | Farydak (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $98.46 | General |
| Category: Oral Oncologic | ||||||
| 02/14/2020 | Secura Bio, Inc. | Farydak (Drug) | Honoraria | Cash or cash equivalent | $1,500.00 | General |
| Category: Oral Oncologic | ||||||
| 06/03/2018 | Janssen Scientific Affairs, LLC | DARZALEX (Biological), IMBRUVICA, Erleada | Food and Beverage | In-kind items and services | $32.71 | General |
| Category: Oncology | ||||||
| 02/15/2018 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $120.61 | General |
| Category: ONCOLOGY | ||||||
| 01/25/2018 | Takeda Pharmaceuticals U.S.A., Inc. | NINLARO (Drug) | Consulting Fee | Cash or cash equivalent | $2,750.00 | General |
| Category: Oncology | ||||||
| 01/25/2018 | Takeda Pharmaceuticals U.S.A., Inc. | NINLARO (Drug) | Food and Beverage | In-kind items and services | $113.34 | General |
| Category: Oncology | ||||||
| 01/25/2018 | Takeda Pharmaceuticals U.S.A., Inc. | NINLARO (Drug) | Travel and Lodging | In-kind items and services | $36.00 | General |
| Category: Oncology | ||||||
| 06/26/2017 | E.R. Squibb & Sons, L.L.C. | EMPLICITI (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,000.00 | General |
| Category: Oncology | ||||||
| 01/20/2017 | E.R. Squibb & Sons, L.L.C. | EMPLICITI (Biological) | Consulting Fee | Cash or cash equivalent | $250.00 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 377 | 992 | $268,132 | $89,328 |
| 2022 | 8 | 462 | 1,083 | $255,510 | $84,566 |
| 2021 | 7 | 423 | 913 | $209,922 | $72,446 |
| 2020 | 8 | 402 | 999 | $213,987 | $63,264 |
Total Patients
1,664
Total Services
3,987
Medicare Billing
$309,604
Procedure Codes
30
All Medicare Procedures & Services
30 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 94 | 331 | $95,444 | $35,390 | 37.1% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 59 | 368 | $102,542 | $33,626 | 32.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 96 | 142 | $30,433 | $9,052 | 29.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 34 | 34 | $14,059 | $3,961 | 28.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 58 | 77 | $11,011 | $3,194 | 29.0% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 21 | 25 | $6,938 | $2,106 | 30.4% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 15 | 15 | $7,705 | $1,998 | 25.9% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 70 | 333 | $88,245 | $26,349 | 29.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 70 | 203 | $56,028 | $21,738 | 38.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 100 | 217 | $44,485 | $15,002 | 33.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 97 | 144 | $19,728 | $6,723 | 34.1% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 38 | 96 | $17,760 | $5,291 | 29.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 37 | 37 | $14,578 | $4,959 | 34.0% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 16 | 16 | $7,952 | $2,453 | 30.9% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 34 | 37 | $6,734 | $2,050 | 30.4% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 82 | 263 | $72,588 | $29,038 | 40.0% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 61 | 199 | $52,735 | $15,946 | 30.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 96 | 204 | $41,820 | $13,995 | 33.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 100 | 137 | $18,769 | $5,808 | 30.9% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 34 | 58 | $10,730 | $3,205 | 29.9% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 18 | 18 | $7,092 | $2,540 | 35.8% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2021 | 32 | 34 | $6,188 | $1,915 | 30.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 83 | 307 | $62,935 | $18,517 | 29.4% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 56 | 178 | $47,170 | $14,524 | 30.8% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 33 | 103 | $28,428 | $8,639 | 30.4% |
About Anastasios Raptis
Anastasios Raptis is a Hematology & Oncology healthcare provider based in Pittsburgh, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/13/2006. The National Provider Identifier (NPI) number assigned to this provider is 1962475509.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Anastasios Raptis has received a total of $7,129 in payments from pharmaceutical and medical device companies, with $101.12 received in 2023. These payments were reported across 13 transactions from 9 companies. The most common payment nature is "Consulting Fee" ($3,000).
As a Medicare-enrolled provider, Raptis has provided services to 1,664 Medicare beneficiaries, totaling 3,987 services with total Medicare billing of $309,604. Data is available for 4 years (2020–2023), covering 30 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology & Oncology
- Location Pittsburgh, PA
- Active Since 02/13/2006
- Last Updated 05/24/2021
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1962475509
Products in Payments
- NINLARO (Drug) $2,899
- EMPLICITI (Biological) $2,250
- Farydak (Drug) $1,598
- KEYTRUDA (Biological) $120.61
- ADCETRIS (Biological) $101.12
- DARZALEX (Biological) $32.71
- BELEODAQ (Drug) $13.93
- XPOVIO (Drug) $12.45
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Pittsburgh
Salman Fazal, M.d, M.D
Hematology & Oncology — Payments: $2.2M
Hematology & Oncology $2.2M
Cyrus Khan, M.d, M.D
Hematology & Oncology — Payments: $2.2M
Hematology & Oncology $2.2M
Dr. Alexander Barsouk, Md, MD
Hematology & Oncology — Payments: $905,454
Hematology & Oncology $905,454
Taofeek Owonikoko, M.d, M.D
Hematology & Oncology — Payments: $454,396
Hematology & Oncology $454,396
Dr. Hashem Younes, M.d, M.D
Hematology & Oncology — Payments: $451,665
Hematology & Oncology $451,665
Dr. Jason Luke, M.d, M.D
Hematology & Oncology — Payments: $431,360
Hematology & Oncology $431,360